Related references
Note: Only part of the references are listed.Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy
Hiroshige Fujishiro et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Physiological Changes in Human Cardiac Sympathetic Innervation and Activity Assessed by 123I-Metaiodobenzylguanidine (MIBG) Imaging
Kazuyuki Sakata et al.
CIRCULATION JOURNAL (2009)
Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies
Seiju Kobayashi et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Cardiac 123I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life
Montserrat Estorch et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study
Kenji Wada-Isoe et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD
M. Yoshita et al.
NEUROLOGY (2006)
The role of I-123-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic
Haruo Hanyu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease
S Orimo et al.
ACTA NEUROPATHOLOGICA (2005)
Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies
T Oide et al.
INTERNAL MEDICINE (2003)
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies
AR Merdes et al.
NEUROLOGY (2003)
A clinical role for [123I] MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies
M Yoshita et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Cardiac 123I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies:: comparison with Alzheimer's disease
H Watanabe et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium
S Mayer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)